Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
NCT06782217
·
clinicaltrials.gov ↗
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy, Insect Venom
Allergy Insect Stinging
Insect Sting Allergy
Interventions
BIOLOGICAL:
VENOX
Sponsor
Inmunotek S.L.